Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|July 22, 2025
Updates in juvenile dermatomyositis: pathogenesis and therapySamantha L Coss, Sara E Sabbagh, Hanna Kim
The Journal of Investigative Dermatology|November 12, 2024
Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted TherapiesKristen L Chen, Yvonne E Chiu, Ruth Ann Vleugels, et al.
Rheumatology (Oxford, England)|September 25, 2025
PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathiesEmma M Austenfeld, Sara E Sabbagh, Melodee Liegl, et al.
Rheumatology (Oxford, England)|May 5, 2023
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositisRie Karasawa, Kazuo Yudoh, Toshiko Sato, et al.
Clinical Rheumatology|April 14, 2021
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositisSara E Sabbagh, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Frontiers in Immunology|July 4, 2024
Corrigendum: Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8<sup>+</sup> T cell repertoire response to influenza vaccinationSara E Sabbagh, Dipica Haribhai, Jill A Gershan, et al.
Frontiers in Immunology|June 14, 2024
Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8<sup>+</sup> T cell repertoire response to influenza vaccinationSara E Sabbagh, Dipica Haribhai, Jill A Gershan, et al.
Annals of the Rheumatic Diseases|September 7, 2025
Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtypeJessica Neely, Sara E Sabbagh, Jeffrey Dvergsten, et al.
Rheumatology (Oxford, England)|August 12, 2022
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease featuresMatthew A Sherman, Rose Graf, Sara E Sabbagh, et al.
Rheumatology (Oxford, England)|September 5, 2020
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North AmericaSara E Sabbagh, Jessica Neely, Albert Chow, et al.
Pageof 2